AU Patent

AU2018246214B2 — Niraparib compositions

Assigned to Merck Sharp and Dohme LLC · Expires 2021-07-08 · 5y expired

What this patent protects

The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.

USPTO Abstract

The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.

Drugs covered by this patent

Patent Metadata

Patent number: AU2018246214B2
Jurisdiction: AU
Classification: —
Expires: 2021-07-08
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.